Eddie Hickman
Stock Analyst at Guggenheim
(0.8)
# 2290
Out of 5,368 analysts
18
Total ratings
41.67%
Success rate
9.56%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
TARS Tarsus Pharmaceutica... | Maintains: Strong Buy | 78 84 | 40.92 | 105.28% | 8 | May 2, 2025 | |
PMN ProMIS Neurosciences | Reiterates: Buy | 6 6 | 0.52 | 1053.85% | 2 | Apr 1, 2025 | |
ZVRA Zevra Therapeutics | Maintains: Strong Buy | 20 22 | 9.11 | 141.49% | 1 | Mar 13, 2025 | |
GHRS GH Research | Initiates Coverage On: Buy | 32 | 12.64 | 153.16% | 1 | Mar 13, 2025 | |
CYBN Cybin | Initiates Coverage On: Buy | 35 | 8.35 | 319.16% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 1.82 | 559.34% | 3 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | May 1, 2023 |